Multifaced Anticancer Potential of Doxorubicin: Spotlight on Breast Cancer
Diseases & Research · 2025 · 5 (1) · 19-36
DOI: 10.54457/dr.202402015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diseases & Research, 2025. Verfasst von Laxita Swain und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, MITS School of Biotechnology, 2(P), Infocity, Patia, Chandaka Industrial Estate, Bhubaneswar, Odisha 751024, India. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, MITS School of Biotechnology, 2(P), Infocity, Patia, Chandaka Industrial Estate, Bhubaneswar, Odisha 751024, India.
- Department of Molecular, Cell and Developmental Biology, University of California, 1156 High Street, Santa Cruz 95064, USA.
- Department of Leukemia, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston 77030, USA.
- Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Chocimska 5, Warsaw 00795, Poland.
Förderung
- NCI NIH HHS
Zitieren
APA
Swain, L., Das, B., & Baran, N. (2025). Multifaced Anticancer Potential of Doxorubicin: Spotlight on Breast Cancer. Diseases & Research, 5(1), 19-36. https://doi.org/10.54457/dr.202402015
Vancouver
Swain L, Das B, Baran N. Multifaced Anticancer Potential of Doxorubicin: Spotlight on Breast Cancer. Diseases & Research. 2025;5(1):19-36. doi:10.54457/dr.202402015
BibTeX
@article{Swain2025,
author = {Swain, Laxita and Das, Biswajit and Baran, Natalia},
title = {Multifaced Anticancer Potential of Doxorubicin: Spotlight on Breast Cancer},
journal = {Diseases & Research},
year = {2025},
volume = {5},
number = {1},
pages = {19--36},
doi = {10.54457/dr.202402015}
}
EUVIMED